Lymphocytopenia as a Prognostic Marker for Diffuse Large B Cell Lymphoma
Lymphocytopenia has been reported to confer adverse outcomes in a number of hematological malignancies. Recently, it has been reported to be associated with poor outcome in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to determine the
|Collections||ANU Research Publications|
|Source:||Leukemia & Lymphoma|
|01_Talaulikar_Lymphocytopenia_as_a_2008.pdf||214.8 kB||Adobe PDF||Request a copy|
|02_Talaulikar_Lymphocytopenia_as_a_2008.pdf||74.65 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.